Neurogenic factor-induced Langerhans cell activation in diabetic mice with mechanical allodynia

Journal of Neuroinflammation

Volumn 10, Issue , 2013, Pages

  Dauch, Jacqueline R ^a   Bender, Diane E ^a   Luna Wong, Lucía A ^a   Hsieh, Wilson ^a   Yanik, Brandon M ^a   Kelly, Zachary A ^a   Cheng, Hsinlin T ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Db db mouse; Langerhans cells; Mechanical allodynia; P38; Painful diabetic neuropathy; Tumor necrosis factor ; Type 2 diabetes

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BIOLOGICAL MARKER; CD68 ANTIGEN; CELL PROTEIN; LANGERIN; NERVE GROWTH FACTOR RECEPTOR; PHOSPHOTRANSFERASE; PROTEIN GENE PRODUCT 9.5; TROPOMYOSIN RECEPTOR KINASE A; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL ASSAY; CELL DENSITY; CELL POPULATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIABETES MELLITUS; EPIDERMIS CELL; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; MALE; MOUSE; NERVE FIBER; NERVE PLEXUS; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION;

EID: 84877617500     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-10-64     Document Type: Article

References (44)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27(5):1047-1053. 10.2337/diacare.27.5.1047, 15111519.
2. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D, American Diabetes Association Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005, 28(4):956-962. 10.2337/diacare.28.4.956, 15793206, American Diabetes Association.
3. Feldman EL, Stevens MJ, Russell JW, Peltier A. Somatosensory neuropathy. The Diabetes Mellitus Manual: A Primary Care Companion to Ellenberg & Rifkin's 2005, 366-384. New York: McGraw-Hill, Inzucchi SE, 6.
4. Calcutt NA. Potential mechanisms of neuropathic pain in diabetes. Int Rev Neurobiol 2002, 50:205-228.
5. Veves A, Backonja M, Malik RA. Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med 2008, 9(6):660-674. 10.1111/j.1526-4637.2007.00347.x, 18828198.
6. Edwards JL, Vincent AM, Cheng HT, Feldman EL. Diabetic neuropathy: mechanisms to management. Pharmacol Ther 2008, 120(1):1-34. 10.1016/j.pharmthera.2008.05.005, 18616962.
7. Barrett AM, Lucero MA, Le T, Robinson RL, Dworkin RH, Chappell AS. Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med 2007, 8(Suppl 2):S50-S62.
8. Nguyen DV, Shaw LC, Grant MB. Inflammation in the pathogenesis of microvascular complications in diabetes. Front Endocrinol (Lausanne) 2012, 3:170.
9. Cruz NG, Sousa LP, Sousa MO, Pietrani NT, Fernandes AP, Gomes KB. The linkage between inflammation and type 2 diabetes mellitus. Diabetes Res Clin Pract 2013, 99(2):85-92. 10.1016/j.diabres.2012.09.003, 23245808.
10. Ziegler D. Type 2 diabetes as an inflammatory cardiovascular disorder. Curr Mol Med 2005, 5(3):309-322. 10.2174/1566524053766095, 15892650.
11. Lim AK, Tesch GH. Inflammation in diabetic nephropathy. Mediators Inflamm 2012, 2012:146154. 3432398, 22969168.
12. Chistiakov DA. Diabetic retinopathy: pathogenic mechanisms and current treatments. Diabetes Metab Syndr 2011, 5(3):165-172. 10.1016/j.dsx.2012.02.025, 22813573.
13. Kanter JE, Kramer F, Barnhart S, Averill MM, Vivekanandan-Giri A, Vickery T, Li LO, Becker L, Yuan W, Chait A, Braun KR, Potter-Perigo S, Sanda S, Wight TN, Pennathur S, Serhan CN, Heinecke JW, Coleman RA, Bornfeldt KE. Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. Proc Natl Acad Sci USA 2012, 109(12):E715-E724. 10.1073/pnas.1111600109, 3311324, 22308341.
14. Blank SE, Johnson EC, Weeks DK, Wysham CH. Circulating dendritic cell number and intracellular TNF-alpha production in women with type 2 diabetes. Acta Diabetol 2012, 49(Suppl 1):25-32.
15. Sakowicz-Burkiewicz M, Pawelczyk T. Recent advances in understanding the relationship between adenosine metabolism and the function of T and B lymphocytes in diabetes. J Physiol Pharmacol 2011, 62(5):505-512.
16. Cheng HT, Dauch JR, Hayes JM, Hong Y, Feldman EL. Nerve growth factor mediates mechanical allodynia in a mouse model of type 2 diabetes. J Neuropathol Exp Neurol 2009, 68(11):1229-1243. 10.1097/NEN.0b013e3181bef710, 3163104, 19816194.
17. Cheng HT, Dauch JR, Oh SS, Hayes JM, Hong Y, Feldman EL. p38 mediates mechanical allodynia in a mouse model of type 2 diabetes. Mol Pain 2010, 6:28. 10.1186/1744-8069-6-28, 2881061, 20482876.
18. Schuler G, Steinman RM. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med 1985, 161(3):526-546. 10.1084/jem.161.3.526, 2187584, 3871837.
19. Ginhoux F, Tacke F, Angeli V, Bogunovic M, Loubeau M, Dai XM, Stanley ER, Randolph GJ, Merad M. Langerhans cells arise from monocytes in vivo. Nat Immunol 2006, 7(3):265-273. 10.1038/ni1307, 16444257.
20. Chorro L, Sarde A, Li M, Woollard KJ, Chambon P, Malissen B, Kissenpfennig A, Barbaroux JB, Groves R, Geissmann F. Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network. J Exp Med 2009, 206(13):3089-3100. 10.1084/jem.20091586, 2806478, 19995948.
21. Tang HL, Cyster JG. Chemokine Up-regulation and activated T cell attraction by maturing dendritic cells. Science 1999, 284(5415):819-822. 10.1126/science.284.5415.819, 10221917.
22. Casanova-Molla J, Morales M, Planas-Rigol E, Bosch A, Calvo M, Grau-Junyent JM, Valls-Solé J. Epidermal Langerhans cells in small fiber neuropathies. Pain 2012, 153(5):982-989. 10.1016/j.pain.2012.01.021, 22361736.
23. Lauria G, Lombardi R, Camozzi F, Devigili G. Skin biopsy for the diagnosis of peripheral neuropathy. Histopathology 2009, 54(3):273-285. 10.1111/j.1365-2559.2008.03096.x, 18637969.
24. Tavakoli M, Boulton AJ, Efron N, Malik RA. Increased Langerhan cell density and corneal nerve damage in diabetic patients: role of immune mechanisms in human diabetic neuropathy. Cont Lens Anterior Eye 2011, 34(1):7-11. 10.1016/j.clae.2010.08.007, 3017662, 20851037.
25. Siau C, Xiao W, Bennett GJ. Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells. Exp Neurol 2006, 201(2):507-514. 10.1016/j.expneurol.2006.05.007, 1805691, 16797537.
26. Hsieh ST, Choi S, Lin WM, Chang YC, Mcarthur JC, Griffin JW. Epidermal denervation and its effects on keratinocytes and Langerhans cells. J Neurocytol 1996, 25(9):513-524.
27. Lindenlaub T, Sommer C. Epidermal innervation density after partial sciatic nerve lesion and pain-related behavior in the rat. Acta Neuropathol 2002, 104(2):137-143. 10.1007/s00401-002-0527-7, 12111356.
28. Noga O, Peiser M, Altenähr M, Knieling H, Wanner R, Hanf G, Grosse R, Suttorp N. Differential activation of dendritic cells by nerve growth factor and brain-derived neurotrophic factor. Clin Exp Allergy 2007, 37(11):1701-1708. 10.1111/j.1365-2222.2007.02832.x, 17892512.
29. Donnerer J, Schuligoi R, Stein C. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience 1992, 49(3):693-698. 10.1016/0306-4522(92)90237-V, 1380138.
30. Woolf CJ, Allchorne A, Safieh-Garabedian B, Poole S. Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol 1997, 121(3):417-424. 10.1038/sj.bjp.0701148, 1564704, 9179382.
31. Randolph GJ, Sanchez-Schmitz G, Angeli V. Factors and signals that govern the migration of dendritic cells via lymphatics: recent advances. Springer Semin Immunopathol 2005, 26(3):273-287. 10.1007/s00281-004-0168-0, 15338191.
32. Chorro L, Geissmann F. Development and homeostasis of 'resident' myeloid cells: the case of the Langerhans cell. Trends Immunol 2010, 31(12):438-445. 10.1016/j.it.2010.09.003, 21030305.
33. Geissmann F, Dieu-Nosjean MC, Dezutter C, Valladeau J, Kayal S, Leborgne M, Brousse N, Saeland S, Davoust J. Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J Exp Med 2002, 196(4):417-430. 10.1084/jem.20020018, 2196053, 12186835.
34. Merad M, Manz MG, Karsunky H, Wagers A, Peters W, Charo I, Weissman IL, Cyster JG, Engleman EG. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat Immunol 2002, 3(12):1135-1141. 10.1038/ni852, 12415265.
35. Manfredi AA, Capobianco A, Esposito A, De Cobelli F, Canu T, Monno A, Raucci A, Sanvito F, Doglioni C, Nawroth PP, Bierhaus A, Bianchi ME, Rovere-Querini P, Del Maschio A. Maturing dendritic cells depend on RAGE for in vivo homing to lymph nodes. J Immunol 2008, 180(4):2270-2275.
36. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001, 104(4):487-501. 10.1016/S0092-8674(01)00237-9, 11239407.
37. Sommer C, Kress M. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett 2004, 361(1-3):184-187.
38. Schäfers M, Geis C, Svensson CI, Luo ZD, Sommer C. Selective increase of tumour necrosis factor-alpha in injured and spared myelinated primary afferents after chronic constrictive injury of rat sciatic nerve. Eur J Neurosci 2003, 17(4):791-804. 10.1046/j.1460-9568.2003.02504.x, 12603269.
39. Schäfers M, Geis C, Brors D, Yaksh TL, Sommer C. Anterograde transport of tumor necrosis factor-alpha in the intact and injured rat sciatic nerve. J Neurosci 2002, 22(2):536-545.
40. Leem JG, Bove GM. Mid-axonal tumor necrosis factor-alpha induces ectopic activity in a subset of slowly conducting cutaneous and deep afferent neurons. J Pain 2002, 3(1):45-49. 10.1054/jpai.2002.27138, 14622853.
41. Sorkin LS, Xiao WH, Wagner R, Myers RR. Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience 1997, 81(1):255-262. 10.1016/S0306-4522(97)00147-4, 9300418.
42. Kimber I, Cumberbatch M. Stimulation of Langerhans cell migration by tumor necrosis factor alpha (TNF-alpha). J Invest Dermatol 1992, 99(5):48S-50S. 10.1111/1523-1747.ep12668986, 1431209.
43. Cheng HT, Dauch JR, Hayes JM, Yanik BM, Feldman EL. Nerve growth factor/p38 signaling increases intraepidermal nerve fiber densities in painful neuropathy of type 2 diabetes. Neurobiol Dis 2012, 45(1):280-287. 10.1016/j.nbd.2011.08.011, 3225563, 21872660.
44. Machelska H. Dual peripheral actions of immune cells in neuropathic pain. Arch Immunol Ther Exp (Warsz) 2011, 59(1):11-24.